Stockreport

Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences

Sagimet Biosciences Inc. - Series A  (SGMT) 
PDF SAN MATEO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel ther [Read more]